Hermes Cornelia, König Gabriele M, Crüsemann Max
Institute of Pharmaceutical Biology, Rheinische Friedrich-Wilhelms-University of Bonn, 53115 Bonn, Germany.
Nat Prod Rep. 2021 Dec 15;38(12):2276-2292. doi: 10.1039/d1np00005e.
Covering: up to April 2021The bacterial cyclic depsipeptides FR900359 (FR) and YM-254890 (YM) were shown to selectively inhibit Gαq proteins with high potency and selectivity and have recently emerged as valuable pharmacological tools due to their effective mechanism of action. Here, we summarize important aspects of this small and specialized natural product family, for which we propose the name chromodepsins, starting from their discovery, producing organisms and structural variety. We then review biosynthesis, structure-activity relationships and ecological and evolutionary aspects of the chromodepsins. Lastly, we discuss their mechanism of action, potential medicinal applications and future opportunities and challenges for further use and development of these complex inhibitor molecules from nature.
截至2021年4月
细菌环缩肽FR900359(FR)和YM-254890(YM)已被证明能高效且选择性地抑制Gαq蛋白,并且由于其有效的作用机制,最近已成为有价值的药理学工具。在此,我们从其发现、产生菌和结构多样性出发,总结了这个小型且特殊的天然产物家族的重要方面,我们提议将其命名为嗜铬缩肽。然后,我们综述了嗜铬缩肽的生物合成、构效关系以及生态和进化方面。最后,我们讨论了它们的作用机制、潜在的医学应用以及进一步利用和开发这些复杂的天然抑制剂分子面临的未来机遇和挑战。